TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy
about
In Vivo Delivery Systems for Therapeutic Genome EditingA Small Molecule Inhibitor Selectively Induces Apoptosis in Cells Transformed by High Risk Human Papilloma VirusesTALEN based HPV-E7 editing triggers necrotic cell death in cervical cancer cellsGenome editing and the next generation of antiviral therapy.B3GNT3 Expression Is a Novel Marker Correlated with Pelvic Lymph Node Metastasis and Poor Clinical Outcome in Early-Stage Cervical Cancer.Detection of treatment-resistant infectious HIV after genome-directed antiviral endonuclease therapy.Proteomics-based identification of VDAC1 as a tumor promoter in cervical carcinomaCRISPR-Cas9 systems: versatile cancer modelling platforms and promising therapeutic strategies.Non-viral delivery of genome-editing nucleases for gene therapy.LKB1 as a Tumor Suppressor in Uterine Cancer: Mouse Models and Translational Studies.Therapeutic gene editing: delivery and regulatory perspectivesCD38 enhances the proliferation and inhibits the apoptosis of cervical cancer cells by affecting the mitochondria functions.Therapeutic vaccines for high-risk HPV-associated diseases.Genome editing technologies to fight infectious diseases.Eradication of cervical cancer in vivo by an AAV vector that encodes shRNA targeting human papillomavirus type 16 E6/E7.The past and presence of gene targeting: from chemicals and DNA via proteins to RNA.Nuclear lactate dehydrogenase A senses ROS to produce α-hydroxybutyrate for HPV-induced cervical tumor growthThe precision prevention and therapy of HPV-related cervical cancer: new concepts and clinical implications
P2860
Q26748886-E1553881-49C5-4550-917D-D2588770131DQ28550190-A5DB66BD-1CF0-4087-BED7-760B4634F1D8Q33905878-C28DC6D0-57E2-4456-8E9C-BD0EABE863DEQ34529971-5FF181D7-DA90-4C78-8024-A3037021C6FAQ35879359-E5FFC594-F2A0-462C-8722-A0578009EBD1Q36494284-DCEF0FB4-A816-42BA-A618-DF8C3B0D954DQ37588452-BAB3D376-51EF-48C8-B70E-62601BAB687BQ38516454-BD3904AA-C9FC-4CFF-BCB1-3506FD8E89BCQ38802151-0416E9D0-B7DA-4E67-96F8-09A727293FA5Q39026772-8865A23C-2D98-47F3-A9EE-A29C9D2F183DQ39230418-21736EBC-46D1-41C4-84AC-19DB7F8E4436Q46360856-225CEFAE-C154-41C0-949F-5AD7E0A26406Q47255618-1B3906CB-E7EA-4FD5-8CA3-841F3686E42EQ47392998-8BA23B40-3208-42CB-AB6A-512D6F4F8166Q47552093-653E21B2-B466-4A38-A726-D17342BB3C2BQ52431809-701D4BB5-7CBD-4DB2-B829-99465B038B9DQ57793552-9FBA7E6E-11B7-4DCF-89E4-9AE21A763456Q58738110-BCF25093-4D3D-43DE-AC1B-6D3C86F3A4BC
P2860
TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy
@ast
TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy
@en
type
label
TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy
@ast
TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy
@en
prefLabel
TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy
@ast
TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy
@en
P2093
P2860
P50
P356
P1476
TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy
@en
P2093
Changlin Zhang
Changyu Wang
Jianfeng Zhou
Juncheng Wei
P2860
P304
P356
10.1172/JCI78206
P407
P577
2014-12-15T00:00:00Z